Literature DB >> 27108939

Associations between scar characteristics by cardiac magnetic resonance and changes in left ventricular ejection fraction in primary prevention defibrillator recipients.

Yiyi Zhang1, Eliseo Guallar1, Robert G Weiss2, Michael Stillabower3, Gary Gerstenblith2, Gordon F Tomaselli2, Katherine C Wu4.   

Abstract

BACKGROUND: Left ventricular ejection fraction (LVEF) improves over time in 25%-40% of patients with cardiomyopathy with primary prevention implantable cardioverter-defibrillator (ICD). The determinants of LVEF improvement, however, are not well characterized.
OBJECTIVES: We sought to examine the associations of clinical risk factors and cardiac imaging markers with changes in LVEF after ICD implantation.
METHODS: We conducted a retrospective analysis of cardiac magnetic resonance images in 202 patients who underwent primary prevention ICD implantation to quantify the amount of heterogeneous myocardial tissue (gray zone), dense core, and total scar. LVEF was reassessed at least once after ICD implantation.
RESULTS: Over a mean follow-up of 3 years, LVEF decreased in 43 (21.3%), improved in 88 (43.6%), and was unchanged in 71 (35.1%) of the patients. Baseline LVEF and myocardial scar characteristics were the strongest determinants of LVEF trajectory with high scar burden and increasing lack of myocardial viability associated with a greater decline in LVEF. There was a trend toward an association between both changes in LVEF and scar extent with subsequent appropriate ICD shock. Changes in LVEF were also strongly associated with heart failure hospitalizations.
CONCLUSION: Scar burden and characteristics were strong determinants, independent of baseline LVEF and other traditional cardiovascular risk factors, of changes in LVEF. Both worsened LVEF and high scar extent were associated with a trend toward increased risk of appropriate shock. These findings suggest that baseline cardiac magnetic resonance imaging of the myocardial substrate may provide important prognostic information on subsequent left ventricular remodeling and adverse events.
Copyright © 2016 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Appropriate shock; Cardiac magnetic resonance; Ejection fraction; Gray zone; Implantable cardioverter-defibrillator; Myocardial scar

Mesh:

Year:  2016        PMID: 27108939      PMCID: PMC4958529          DOI: 10.1016/j.hrthm.2016.04.013

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  34 in total

1.  Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.

Authors:  Stijntje D Roes; C Jan Willem Borleffs; Rob J van der Geest; Jos J M Westenberg; Nina Ajmone Marsan; Theodorus A M Kaandorp; Johan H C Reiber; Katja Zeppenfeld; Hildo J Lamb; Albert de Roos; Martin J Schalij; Jeroen J Bax
Journal:  Circ Cardiovasc Imaging       Date:  2009-03-23       Impact factor: 7.792

2.  Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality.

Authors:  Andrew T Yan; Adolphe J Shayne; Kenneth A Brown; Sandeep N Gupta; Carmen W Chan; Tuan M Luu; Marcelo F Di Carli; H Glenn Reynolds; William G Stevenson; Raymond Y Kwong
Journal:  Circulation       Date:  2006-06-26       Impact factor: 29.690

3.  Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators.

Authors:  M A Konstam; M F Rousseau; M W Kronenberg; J E Udelson; J Melin; D Stewart; N Dolan; T R Edens; S Ahn; D Kinan
Journal:  Circulation       Date:  1992-08       Impact factor: 29.690

4.  Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death.

Authors:  Leah Iles; Heinz Pfluger; Lisa Lefkovits; Michelle J Butler; Peter M Kistler; David M Kaye; Andrew J Taylor
Journal:  J Am Coll Cardiol       Date:  2011-02-15       Impact factor: 24.094

5.  Incidence of appropriate shock in implantable cardioverter-defibrillator patients with improved ejection fraction.

Authors:  Niyada Naksuk; Ali Saab; Jian-Ming Li; Viorel Florea; Mehmet Akkaya; Inder S Anand; David G Benditt; Selcuk Adabag
Journal:  J Card Fail       Date:  2013-06       Impact factor: 5.712

6.  Changes in Follow-Up Left Ventricular Ejection Fraction Associated With Outcomes in Primary Prevention Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Recipients.

Authors:  Yiyi Zhang; Eliseo Guallar; Elena Blasco-Colmenares; Barbara Butcher; Sanaz Norgard; Victor Nauffal; Joseph E Marine; Zayd Eldadah; Timm Dickfeld; Kenneth A Ellenbogen; Gordon F Tomaselli; Alan Cheng
Journal:  J Am Coll Cardiol       Date:  2015-08-04       Impact factor: 24.094

7.  Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HeFT VA Cooperative Studies Group.

Authors:  G Cintron; G Johnson; G Francis; F Cobb; J N Cohn
Journal:  Circulation       Date:  1993-06       Impact factor: 29.690

8.  Focal But Not Diffuse Myocardial Fibrosis Burden Quantification Using Cardiac Magnetic Resonance Imaging Predicts Left Ventricular Reverse Modeling Following Cardiac Resynchronization Therapy.

Authors:  Zhong Chen; Manav Sohal; Eva Sammut; Nick Child; Tom Jackson; Simon Claridge; Michael Cooklin; Mark O'Neill; Matthew Wright; Jaswinder Gill; Amedeo Chiribiri; Tobias Schaeffter; Gerry Carr-White; Reza Razavi; C Aldo Rinaldi
Journal:  J Cardiovasc Electrophysiol       Date:  2015-12-17

9.  Prospective observational study of implantable cardioverter-defibrillators in primary prevention of sudden cardiac death: study design and cohort description.

Authors:  Alan Cheng; Darshan Dalal; Barbara Butcher; Sanaz Norgard; Yiyi Zhang; Timm Dickfeld; Zayd A Eldadah; Kenneth A Ellenbogen; Eliseo Guallar; Gordon F Tomaselli
Journal:  J Am Heart Assoc       Date:  2013-02-22       Impact factor: 5.501

10.  Scar heterogeneity on cardiovascular magnetic resonance as a predictor of appropriate implantable cardioverter defibrillator therapy.

Authors:  Hussein Rayatzadeh; Alex Tan; Raymond H Chan; Shalin J Patel; Thomas H Hauser; Long Ngo; Jaime L Shaw; Susie N Hong; Peter Zimetbaum; Alfred E Buxton; Mark E Josephson; Warren J Manning; Reza Nezafat
Journal:  J Cardiovasc Magn Reson       Date:  2013-04-10       Impact factor: 5.364

View more
  8 in total

Review 1.  Sudden Cardiac Death Substrate Imaged by Magnetic Resonance Imaging: From Investigational Tool to Clinical Applications.

Authors:  Katherine C Wu
Journal:  Circ Cardiovasc Imaging       Date:  2017-07       Impact factor: 7.792

2.  Relationship between Extension or Texture Features of Late Gadolinium Enhancement and Ventricular Tachyarrhythmias in Hypertrophic Cardiomyopathy.

Authors:  Yasuo Amano; Yasuyuki Suzuki; Fumi Yanagisawa; Yuko Omori; Naoya Matsumoto
Journal:  Biomed Res Int       Date:  2018-09-09       Impact factor: 3.411

3.  CinE caRdiac magneTic resonAnce to predIct veNTricular arrhYthmia (CERTAINTY).

Authors:  Katherine C Wu; Hiroshi Ashikaga; Julian Krebs; Tommaso Mansi; Hervé Delingette; Bin Lou; Joao A C Lima; Susumu Tao; Luisa A Ciuffo; Sanaz Norgard; Barbara Butcher; Wei H Lee; Ela Chamera; Timm-Michael Dickfeld; Michael Stillabower; Joseph E Marine; Robert G Weiss; Gordon F Tomaselli; Henry Halperin
Journal:  Sci Rep       Date:  2021-11-22       Impact factor: 4.996

Review 4.  Arrhythmic risk stratification in ischemic, non-ischemic and hypertrophic cardiomyopathy: A two-step multifactorial, electrophysiology study inclusive approach.

Authors:  Petros Arsenos; Konstantinos A Gatzoulis; Dimitrios Tsiachris; Polychronis Dilaveris; Skevos Sideris; Ilias Sotiropoulos; Stefanos Archontakis; Christos-Konstantinos Antoniou; Athanasios Kordalis; Ioannis Skiadas; Konstantinos Toutouzas; Charalambos Vlachopoulos; Dimitrios Tousoulis; Konstantinos Tsioufis
Journal:  World J Cardiol       Date:  2022-03-26

5.  Improving Clinical Translation of Machine Learning Approaches Through Clinician-Tailored Visual Displays of Black Box Algorithms: Development and Validation.

Authors:  Shannon Wongvibulsin; Katherine C Wu; Scott L Zeger
Journal:  JMIR Med Inform       Date:  2020-06-09

6.  Clinical risk prediction with random forests for survival, longitudinal, and multivariate (RF-SLAM) data analysis.

Authors:  Shannon Wongvibulsin; Katherine C Wu; Scott L Zeger
Journal:  BMC Med Res Methodol       Date:  2019-12-31       Impact factor: 4.615

7.  Baseline and Dynamic Risk Predictors of Appropriate Implantable Cardioverter Defibrillator Therapy.

Authors:  Katherine C Wu; Shannon Wongvibulsin; Susumu Tao; Hiroshi Ashikaga; Michael Stillabower; Timm M Dickfeld; Joseph E Marine; Robert G Weiss; Gordon F Tomaselli; Scott L Zeger
Journal:  J Am Heart Assoc       Date:  2020-10-07       Impact factor: 5.501

8.  Delayed Improvement of Left Ventricular Function in Newly Diagnosed Heart Failure Depends on Etiology-A PROLONG-II Substudy.

Authors:  Johanna Mueller-Leisse; Johanna Brunn; Christos Zormpas; Stephan Hohmann; Henrike Aenne Katrin Hillmann; Jörg Eiringhaus; Johann Bauersachs; Christian Veltmann; David Duncker
Journal:  Sensors (Basel)       Date:  2022-03-05       Impact factor: 3.576

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.